We are live on ! Find out more
VA

Vident Advisory Portfolio holdings

AUM $11.7B
1-Year Est. Return 37.32%
This Fund
S&P 500
This Quarter Est. Return
+4.06%
1 Year Est. Return
+37.32%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.62B
AUM Growth
-$1.18B
Cap. Flow
-$1.18B
Cap. Flow %
-32.7%
Top 10 Hldgs %
16.49%
Holding
1,533
New
211
Increased
794
Reduced
387
Closed
126

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$52.4M
2
JNJ icon
Johnson & Johnson
JNJ
+$39.1M
3
TMUS icon
T-Mobile US
TMUS
+$37.2M
4
ABBV icon
AbbVie
ABBV
+$35.8M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$34.6M

Sector Composition

Rank Sector Weight
1 Technology 29.28%
2 Financials 10.77%
3 Consumer Discretionary 8.99%
4 Industrials 8.73%
5 Healthcare 6.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TMO icon
376
Thermo Fisher Scientific
TMO
$211B
$1.98M 0.05%
3,574
+408
+13% +$234K
JHG
377
DELISTED
Janus Henderson
JHG
$1.98M 0.05%
58,620
-6,072
-9% -$199K
OR icon
378
OR Royalties Inc
OR
$5.47B
$1.97M 0.05%
126,428
+22,715
+22% +$368K
MUFG icon
379
Mitsubishi UFJ Financial
MUFG
$258B
$1.97M 0.05%
182,307
+44,356
+32% +$450K
KT icon
380
KT
KT
$8.84B
$1.96M 0.05%
143,072
+26,397
+23% +$348K
CALM icon
381
Cal-Maine
CALM
$4.28B
$1.94M 0.05%
31,755
+2,974
+10% +$176K
CDP icon
382
COPT Defense Properties
CDP
$4.31B
$1.94M 0.05%
77,333
+2,183
+3% +$52.5K
SAP icon
383
SAP
SAP
$187B
$1.93M 0.05%
9,578
+1,742
+22% +$329K
HAFN icon
384
Hafnia
HAFN
$3.82B
$1.93M 0.05%
+229,117
New +$1.84M
DHI icon
385
D.R. Horton
DHI
$41B
$1.93M 0.05%
13,675
+474
+4% +$69.6K
KMI icon
386
Kinder Morgan
KMI
$73.1B
$1.91M 0.05%
96,037
-137,744
-59% -$2.63M
BBY icon
387
Best Buy
BBY
$18B
$1.91M 0.05%
22,625
+718
+3% +$57K
SO icon
388
Southern Company
SO
$110B
$1.9M 0.05%
+24,480
New +$1.86M
ADI icon
389
Analog Devices
ADI
$181B
$1.89M 0.05%
8,265
+970
+13% +$207K
HPQ icon
390
HP
HPQ
$23.5B
$1.88M 0.05%
53,689
-128,528
-71% -$4.08M
SBSW icon
391
Sibanye-Stillwater
SBSW
$5.92B
$1.88M 0.05%
431,124
+146,548
+51% +$725K
BBWI icon
392
Bath & Body Works
BBWI
$4.01B
$1.87M 0.05%
47,998
+17,543
+58% +$805K
MNST icon
393
Monster Beverage
MNST
$91.4B
$1.87M 0.05%
37,348
+20,095
+116% +$1.07M
VTI icon
394
Vanguard Total Stock Market ETF
VTI
$654B
$1.86M 0.05%
6,961
+2
+0% +$518
SCHW
395
Charles Schwab
SCHW
$177B
$1.86M 0.05%
25,174
+2,064
+9% +$152K
CEG icon
396
Constellation Energy
CEG
$98B
$1.85M 0.05%
9,245
+757
+9% +$154K
OMC icon
397
Omnicom Group
OMC
$22.7B
$1.85M 0.05%
20,618
-160,440
-89% -$14.9M
DOW icon
398
Dow Inc
DOW
$21.6B
$1.85M 0.05%
34,836
+1,397
+4% +$79.8K
BSX icon
399
Boston Scientific
BSX
$65.8B
$1.85M 0.05%
23,966
+4,833
+25% +$354K
INVH icon
400
Invitation Homes
INVH
$17.7B
$1.84M 0.05%
51,362
+2,249
+5% +$78.2K

Similar funds

Vident Advisory's Q2 2024 Portfolio in Review

As of Q2 2024, Vident Advisory held 1,533 positions worth $3.62B, down 25% from $4.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Vident Advisory withdrew a net $1.18B in Q2 2024, closing 126 positions and reducing 387 holdings. Its most notable exit was Enterprise Products Partners, an estimated $20M position sold in full.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 23% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Vident Advisory opened a new position in Vanguard Intermediate-Term Treasury ETF worth $19M.

  • Vident Advisory's largest Q2 2024 buy was Vanguard Intermediate-Term Treasury ETF: 326,646 shares worth $19M.
  • Vident Advisory added most to Tesla in Q2 2024, an estimated $29.1M increase.
  • Vident Advisory's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $52.4M.
  • Vident Advisory fully exited Enterprise Products Partners in Q2 2024, selling an estimated $20M.
  • Vident Advisory's ten largest holdings make up 16% of its $3.62B portfolio in Q2 2024.
  • Vident Advisory opened 211 new positions and closed 126 in Q2 2024.
  • Vident Advisory's portfolio value fell 25% quarter-over-quarter to $3.62B.

Based on Vident Advisory's 13F filing for Q2 2024, filed 14 Aug 2024.